Your session is about to expire
← Back to Search
Behavioural Intervention
Mobile App for Alcoholic Liver Disease (IMPACT-ALD Trial)
N/A
Recruiting
Led By Andrew Quanbeck, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a smartphone app called CHESS Health Connections among patients with alcohol-associated liver disease in Michigan and Wisconsin. The goal is to help patients stop drinking alcohol earlier in their disease and improve their
Who is the study for?
This trial is for individuals with alcohol-associated liver disease (ALD) who are being treated at two medical centers in Michigan and Wisconsin. It's open to patients from general hepatology clinics as well as those receiving integrated care for advanced ALD, mental health, and substance abuse.
What is being tested?
The study is testing the CHESS Health Connections smartphone app's effectiveness in helping ALD patients quit drinking. Participants will be randomly assigned to use the app or not, and their progress will be tracked over a six-month period.
What are the potential side effects?
Since this trial involves a mobile-based program rather than medication, traditional side effects are not expected. However, participants may experience stress or frustration if they find using the app challenging.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months, 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Days of Alcohol Abstinence in ALD Participants
Number of Standard Drinks Consumed in ALD Participants
Secondary study objectives
Change in CHESS Bonding Scale Score
Change in Drinking Motivations Questionnaire - Adult (DMQ-A) Score
Change in Drug-Taking Confidence Questionnaire (DTCQ-8A) Score
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Connections AppExperimental Treatment1 Intervention
The Connections app is based on principles of effective care for substance use disorders, such as sustained duration, peer support, improving coping skills in high-risk situations, assertive outreach, self- monitoring, prompts, and action planning. The theoretical foundation of CHESS Health is self-determination theory, which holds that an individual's adaptive functioning can be improved if the patient feels (1) competent, (2) related to others, and (3) internally motivated rather than coerced in one's actions.
Group II: Treatment as UsualActive Control1 Intervention
Find a Location
Who is running the clinical trial?
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
839 Previous Clinical Trials
1,083,350 Total Patients Enrolled
459 Trials studying Alcoholism
823,533 Patients Enrolled for Alcoholism
National Institute on Drug Abuse (NIDA)NIH
2,605 Previous Clinical Trials
3,329,620 Total Patients Enrolled
71 Trials studying Alcoholism
64,933 Patients Enrolled for Alcoholism
University of Wisconsin, MadisonLead Sponsor
1,237 Previous Clinical Trials
3,200,681 Total Patients Enrolled
12 Trials studying Alcoholism
4,314 Patients Enrolled for Alcoholism
Andrew Quanbeck, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
2 Previous Clinical Trials
826 Total Patients Enrolled
1 Trials studying Alcoholism
558 Patients Enrolled for Alcoholism